We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Increase in Genome-Editing Trials Means Change for Informed Consent Process

News   Oct 13, 2020 | Original story from National Human Genome Research Institute

 
Increase in Genome-Editing Trials Means Change for Informed Consent Process

As genome-editing trials become more common, the process of informed consent is changing. Credit: Ernesto del Aguila III (NHGRI)

 
 
Advertisement
 

RELATED ARTICLES

Anemone Produce Toxins That Have Pharmacological Potential

News

Researchers based in Brazil and the United States have completed the first-ever mapping exercise to profile the toxins produced by tube-dwelling anemones, or cerianthids, a family of marine animals. The analysis revealed that the toxins that can act on the nervous system, cardiovascular system, and cell walls, among other functions, paving the way to the discovery of novel medications.

READ MORE

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Turning the Virus’ RBD Into a Nanoparticle an Appealing Approach for COVID-19 Vaccine

News

A University at Buffalo-led research team has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE